Balchem Co. (NASDAQ:BCPC) Shares Bought by Tributary Capital Management LLC

Tributary Capital Management LLC grew its holdings in shares of Balchem Co. (NASDAQ:BCPC) by 0.3% during the second quarter, Holdings Channel reports. The firm owned 135,185 shares of the basic materials company’s stock after purchasing an additional 364 shares during the quarter. Balchem comprises about 1.7% of Tributary Capital Management LLC’s holdings, making the stock its 19th largest position. Tributary Capital Management LLC’s holdings in Balchem were worth $20,812,000 at the end of the most recent quarter.

Several other hedge funds have also made changes to their positions in BCPC. Signaturefd LLC increased its stake in Balchem by 123.0% during the 4th quarter. Signaturefd LLC now owns 165 shares of the basic materials company’s stock worth $25,000 after buying an additional 91 shares during the period. Principal Securities Inc. purchased a new stake in shares of Balchem during the fourth quarter worth $28,000. Bessemer Group Inc. raised its stake in shares of Balchem by 568.9% in the first quarter. Bessemer Group Inc. now owns 301 shares of the basic materials company’s stock valued at $47,000 after acquiring an additional 256 shares in the last quarter. GAMMA Investing LLC acquired a new stake in shares of Balchem in the fourth quarter valued at $56,000. Finally, YHB Investment Advisors Inc. acquired a new position in Balchem during the 1st quarter worth $69,000. Institutional investors and hedge funds own 87.91% of the company’s stock.

Insider Activity at Balchem

In other news, SVP Gunsteren Job Leonard Van sold 7,750 shares of the company’s stock in a transaction on Wednesday, July 31st. The shares were sold at an average price of $180.05, for a total value of $1,395,387.50. Following the completion of the transaction, the senior vice president now owns 8,540 shares in the company, valued at approximately $1,537,627. The sale was disclosed in a document filed with the SEC, which is available at this link. 1.25% of the stock is currently owned by corporate insiders.

Balchem Stock Up 2.9 %

Shares of BCPC traded up $4.91 during midday trading on Friday, reaching $172.74. The stock had a trading volume of 92,715 shares, compared to its average volume of 107,407. The company has a market cap of $5.60 billion, a price-to-earnings ratio of 48.80, a PEG ratio of 5.63 and a beta of 0.68. The company’s fifty day simple moving average is $165.26 and its two-hundred day simple moving average is $156.21. Balchem Co. has a 1-year low of $110.74 and a 1-year high of $186.03. The company has a debt-to-equity ratio of 0.26, a current ratio of 2.83 and a quick ratio of 1.79.

Balchem (NASDAQ:BCPC) last posted its quarterly earnings results on Friday, July 26th. The basic materials company reported $0.98 earnings per share for the quarter, beating analysts’ consensus estimates of $0.95 by $0.03. Balchem had a return on equity of 10.94% and a net margin of 12.52%. The company had revenue of $234.08 million for the quarter, compared to analysts’ expectations of $241.26 million. Equities research analysts expect that Balchem Co. will post 3.91 earnings per share for the current year.

Analyst Ratings Changes

Several equities research analysts have weighed in on the company. StockNews.com downgraded Balchem from a “buy” rating to a “hold” rating in a report on Monday, July 29th. HC Wainwright upped their target price on shares of Balchem from $170.00 to $185.00 and gave the stock a “buy” rating in a research note on Wednesday, July 31st.

Balchem Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.